Real-world effectiveness and safety of dupilumab in managing children and adolescents with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Marshall, Claire [1 ]
Littlewood, Zoe [1 ]
Herety, Nichola [1 ]
Heal, Calvin [2 ]
Sharif, Jennifer [1 ]
Clayton, Tim [1 ]
机构：
[1] Salford Royal NHS Fdn Trust, Manchester, Lancs, England
[2] Univ Manchester, Ctr Biostat, Manchester, Lancs, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
PA03
引用
收藏
页码：196 / 196
页数：1
相关论文
共 50 条
  • [21] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
    James E. Frampton
    Hannah A. Blair
    [J]. American Journal of Clinical Dermatology, 2018, 19 : 617 - 624
  • [22] Laboratory markers of dupilumab patients with moderate-to-severe atopic dermatitis: a single-center, real-world study
    Hawkins, K.
    Sharma, D.
    Shokrian, N.
    Piontkowski, A.
    Ungar, B.
    Guttman-Yassky, E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S162 - S162
  • [23] Effectiveness and safety of upadacitinib for moderate-to-severe atopic dermatitis in a real-world setting: A 52-week retrospective study
    Gargiulo, L.
    Ibba, L.
    Piscazzi, F.
    Alfano, A.
    Ingurgio, R. Cascio
    Valenti, M.
    Costanzo, A.
    Narcisi, A.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (02) : e152 - e154
  • [24] Dupilumab Improves Clinical Scores in Children and Adolescents With Moderate to Severe Atopic Dermatitis: A Real-World, Single-Center Study
    Pagan, Angel D.
    David, Eden
    Ungar, Benjamin
    Ghalili, Sabrina
    He, Helen
    Guttman-Yassky, Emma
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (09): : 2378 - 2385
  • [25] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Zheng, Y.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 72 - 72
  • [26] Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis
    Cork, M. J.
    Eichenfield, L. F.
    Blauvelt, A.
    Rosmarin, D.
    Hussain, I.
    Davis, J. D.
    Li, M.
    Zhang, Q.
    Gadkari, A.
    Eckert, L.
    Kamal, M. A.
    Bansal, A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S104 - S104
  • [27] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Xu, Xinghua
    Zheng, Yi
    Zhang, Xin
    He, Yanling
    Li, Chengxin
    [J]. ONCOTARGET, 2017, 8 (65) : 108480 - 108491
  • [28] Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children
    Parker, Jennifer J.
    Sugarman, Jeffrey L.
    Silverberg, Nanette B.
    Gonzalez, Mercedes Elena
    Ramien, Michele L.
    Teng, Joyce M. C.
    Paller, Amy S.
    [J]. PEDIATRIC DERMATOLOGY, 2021, 38 (06) : 1500 - 1505
  • [29] Efficacy and Treatment Satisfaction of Different Systemic Therapies in Children and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Real-World Study
    Kiefer, Sebastian
    Koenig, Anke
    Gerger, Viviane
    Rummenigge, Christine
    Mueller, Anne Christine
    Jung, Thomas
    Frank, Alexandra
    Tassopoulos, Georgios
    Laurent, Emilie
    Kaufmann, Roland
    Pinter, Andreas
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
  • [30] Real-world outcomes of children treated with dupilumab for moderate-to-severe atopic dermatitis: a single-centre retrospective observational UK study
    Hosseini-Ashrafi, Mozhgan
    Clayton, Tim H.
    Herring, Michelle
    Herety, Nichola
    Arkwright, Peter D.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (06) : 578 - 583
12345